Inhibition of PRMT5 triggers synthetic lethalityin ARID1A-deficient endometrial cancer by promoting aberrant R-loop accumulation
Favorite
Share
More Options
26

Open in WPS to view all 26 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
